T-cell prolymphocytic leukaemia and Respiratory acidosis

Summary:

Respiratory acidosis is found among people with T-cell prolymphocytic leukaemia, especially for people who are female, 60+ old.

The study analyzes which people have Respiratory acidosis with T-cell prolymphocytic leukaemia. It is created by eHealthMe based on reports of 14 people who have T-cell prolymphocytic leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

14 people who have T-Cell Prolymphocytic Leukaemia and Respiratory Acidosis are studied.


What is T-cell prolymphocytic leukaemia?

T-cell prolymphocytic leukaemia (a aggressive type of t cell cancer) is found to be associated with 80 drugs and 44 conditions by eHealthMe.

What is Respiratory acidosis?

Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease) is found to be associated with 2,881 drugs and 3,093 conditions by eHealthMe.

Number of Respiratory acidosis in T-cell prolymphocytic leukaemia reports submitted per year:

Would you have Respiratory acidosis when you have T-cell prolymphocytic leukaemia?

Gender of people who have T-Cell Prolymphocytic Leukaemia and experienced Respiratory Acidosis *:

  • female: 53.85 %
  • male: 46.15 %

Age of people who have T-Cell Prolymphocytic Leukaemia and experienced Respiratory Acidosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25.0 %
  • 50-59: 16.67 %
  • 60+: 58.33 %

Common co-existing conditions for these people *:

  1. Enlarged Prostate: 1 person, 7.14%
  2. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 7.14%

Common drugs taken by these people *:

  1. Fludara: 5 people, 35.71%
  2. Campath: 5 people, 35.71%
  3. Bactrim: 4 people, 28.57%
  4. Pentostatin: 3 people, 21.43%
  5. Fluconazole: 2 people, 14.29%
  6. Alprazolam: 2 people, 14.29%
  7. Aranesp: 2 people, 14.29%
  8. Atarax: 2 people, 14.29%
  9. Famotidine: 2 people, 14.29%
  10. Allopurinol Sodium: 2 people, 14.29%

Common symptoms for these people *:

  1. Fever: 6 people, 42.86%
  2. Haematoma (collection of blood outside the blood vessels): 5 people, 35.71%
  3. Urine Output - Decreased: 5 people, 35.71%
  4. Capillary Leak Syndrome (capillary leaks plasma): 5 people, 35.71%
  5. Acute Kidney Failure: 5 people, 35.71%
  6. Generalised Oedema (swelling all over the body): 5 people, 35.71%
  7. Gingival Bleeding (bleeding gums): 5 people, 35.71%
  8. Injection Site Haemorrhage (bleeding from injection site): 5 people, 35.71%
  9. Pneumonia: 3 people, 21.43%
  10. Tumor Lysis Syndrome: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Respiratory acidosis?

Check whether Respiratory acidosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Respiratory acidosis:

Common drugs associated with Respiratory acidosis:

All the drugs that are associated with Respiratory acidosis:

Common conditions associated with Respiratory acidosis:

All the conditions that are associated with Respiratory acidosis:

How the study uses the data?

The study is based on Respiratory acidosis and T-cell prolymphocytic leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: